Letter to the Editor
Bone Marrow Transplantation (2007) 39, 189–191. doi:10.1038/sj.bmt.1705554; published online 8 January 2007
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
F Palandri1, M Amabile1, G Rosti1, G Bandini1, F Benedetti2, E Usala3, E Angelucci3, M Tiribelli4, R Fanin4, G Martinelli1 and M Baccarani1
- 1Department of Hematology and Oncology 'L. and A. Seràgnoli', S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 2BMT Unit, Azienda Ospedaliera di Verona, Verona, Italy
- 3Institute of Hematology and Stem Cell Transplantation Unit, 'Armando Businco' Hospital, Cagliari, Italy
- 4Institute of Hematology, University of Udine, Udine, Italy
Correspondence: F Palandri, E-mail: francesca.palandri@libero.it
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Bone Marrow Transplantation Letter
Delayed lymphocyte infusion in children given SCT
Bone Marrow Transplantation Original Article
